English, Article edition: Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom Hugh Freeman; Steve Arikian; Alan Lenox-Smith

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/119135
Physical Description
  • article
Language
  • English

Edition details

Title
  • Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom
Author
  • Hugh Freeman
  • Steve Arikian
  • Alan Lenox-Smith
Physical Description
  • article
Notes
  • Objective: To estimate the cost effectiveness of different classes of antidepressants in the UK National Health Service. Design, patients and interventions: The use of the serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine) reuptake inhibitor (SNRI) venlafaxine was compared with that of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) in patients with major depressive disorder (MDD). A meta-analysis determined the clinical success rate, and a decision tree was constructed by interviewing general practitioners and psychiatrists. Adding pharmacological and nonpharmacological treatment costs, meta-analytic rates were applied to the decision tree to calculate the expected cost and outcome for each drug. Cost effectiveness was determined using a composite measure of outcome [symptom-free days (SFD)]. Main outcome measures and results: The meta-analysis included data from 44 studies on 4033 patients. The highest overall efficacy rate for outpatients with MDD was with venlafaxine use (73.7%), compared with 61.4% for SSRIs and 59.3% for TCAs. Treatment with venlafaxine yielded the lowest outpatient cost for a SFD (Lstg 10.53), compared with Lstg 13.23 for SSRIs and Lstg 15.52 for TCAs (1998 values). Conclusions: Using this economic model, venlafaxine appears to be a cost-effective treatment for outpatients with MDD in the UK.
  • Antidepressants, Cost effectiveness, Depression, Depressive disorders, Meta analysis, Pharmacoeconomics, Serotonin uptake inhibitors, Tricyclic antidepressants, Venlafaxine
  • RePEc:wkh:phecon:v:18:y:2000:i:2:p:143-148
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment